Actinic keratosis treatment market to represent a value of us$ 8 bn by 2028
Answers
Answer:
dif8fofifofogogoggogpgpgpgogogpgogpgpgpg
Explanation:
Actinic Keratosis Treatment Market: Increased Disease Treatment Penetration and Global Adoption of Advanced Combination Therapies Fuelling Revenue Growth: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028
REP-GB-3233 2018-10-17 Category: Healthcare, Pharmaceuticals and Medical devices 275 Pages Format: pdf
Ask The AnalystRequest MethodologyRequest Brochure
Preview Analysis
Top two brands of Photo Dynamic Therapy account for maximum revenue share in the actinic keratosis treatment market
Photodynamic therapy (PDT) is said to be one of the most successful treatment options for actinic keratosis treatment. PDT is mostly been prescribed by the physicians when the topical treatment or Cryotherapy fails. Aminolevulinic acid is applied as a medication on the infected part of the skin during photodynamic therapy for actinic keratosis treatment, which is then activated with a blue light, or intense pulsed light source. Currently, Levulan Kerastick by Sun Pharmaceutical, Ameluz by Biofrontera and Metvix by Galderma are the major products available in the market for photodynamic therapy in actinic keratosis treatment. These brands of photodynamic therapy for actinic keratosis treatment are estimated to gain majority of the market share. The actinic keratosis treatment market is consolidated in nature for PDT products.